Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
BBC vs QAAGZX
Shared holdings
62
BBC covered by QAAGZX
15.77%
QAAGZX covered by BBC
15.77%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
BBC (April 30, 2026)
| Security | Weight | |
|---|---|---|
| DREYFUS GOVT CASH MGMT FUND | 2.23% | |
| ERASCA INC | 2.14% | |
| ENLIVEN THERAPEUTICS INC | 1.77% | |
| TANGO THERAPEUTICS INC | 1.67% | |
| ORUKA THERAPEUTICS INC | 1.64% | |
| SPYRE THERAPEUTICS INC | 1.60% | |
| ALUMIS INC | 1.55% | |
| DIANTHUS THERAPEUTICS INC | 1.51% | |
| KODIAK SCIENCES INC | 1.32% | |
| REVOLUTION MEDICINES INC | 1.32% | |
| CORVUS PHARMACEUTICALS INC | 1.31% | |
| REZOLUTE INC | 1.29% | |
| DEFINIUM THERAPEUTICS INC | 1.26% | |
| CG ONCOLOGY INC | 1.18% | |
| JADE BIOSCIENCES INC | 1.18% | |
| INHIBRX BIOSCIENCES INC | 1.17% | |
| RELAY THERAPEUTICS INC | 1.17% | |
| GH RESEARCH PLC | 1.14% | |
| NEKTAR THERAPEUTICS | 1.12% | |
| TYRA BIOSCIENCES INC | 1.11% | |
| VIR BIOTECHNOLOGY INC | 1.10% | |
| INTELLIA THERAPEUTICS INC | 1.08% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.08% | |
| ANAPTYSBIO INC | 1.06% | |
| OMEROS CORP | 1.04% | |
| TECTONIC THERAPEUTIC INC | 1.02% | |
| ALLOGENE THERAPEUTICS INC | 1.02% | |
| COMPASS Pathways PLC, ADR | 0.97% | |
| EDGEWISE THERAPEUTICS INC | 0.95% | |
| PALVELLA THERAPEUTICS INC | 0.94% | |
| CAPRICOR THERAPEUTICS INC | 0.93% | |
| VAXCYTE INC | 0.93% | |
| PHARVARIS NV | 0.93% | |
| ARRIVENT BIOPHARMA INC | 0.92% | |
| XENON PHARMACEUTICALS INC | 0.92% | |
| NEUROGENE INC | 0.90% | |
| SUMMIT THERAPEUTICS INC | 0.88% | |
| AMYLYX PHARMACEUTICALS INC | 0.88% | |
| CELLDEX THERAPEUTICS INC | 0.86% | |
| PRAXIS PRECISION MEDICINES INC | 0.86% | |
| ARCUS BIOSCIENCES INC | 0.86% | |
| ANNEXON INC | 0.85% | |
| TERNS PHARMACEUTICALS INC | 0.85% | |
| LIQUIDIA TECHNOLOGIES INC | 0.85% | |
| MONTE ROSA THERAPEUTICS INC | 0.85% | |
| IMMUNOME INC | 0.85% | |
| BICARA THERAPEUTICS INC | 0.84% | |
| CELCUITY INC | 0.83% | |
| IRONWOOD PHARMA CL A (PEND) | 0.83% | |
| AbCellera Biologics Inc COM | 0.83% |
QAAGZX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.21% | |
| THERMO FISHER SCIENTIFIC INC | 4.08% | |
| INTUITIVE SURGICAL INC | 3.68% | |
| STRYKER CORP | 3.49% | |
| MERCK & CO | 3.46% | |
| ASTRAZENECA PLC | 3.18% | |
| UNITEDHEALTH GRP | 3.10% | |
| ARGENX SE SPONSORED ADR | 2.93% | |
| ABBVIE INC | 2.88% | |
| REGENERON PHARMACEUTICALS INC | 2.68% | |
| GILEAD SCIENCES INC | 2.61% | |
| JOHNSON&JOHNSON | 2.46% | |
| VERTEX PHARMACEUTICALS INC | 2.43% | |
| DANAHER CORP | 2.05% | |
| ALNYLAM PHARMACEUTICALS INC | 1.63% | |
| Ascendis Pharma A/S | 1.42% | |
| REVOLUTION MEDICINES INC | 1.36% | |
| UNITED THERAPEUTICS CORP DEL | 1.35% | |
| BEONE MEDICINE-H | 1.20% | |
| ROIVANT SCIENCES LTD | 1.13% | |
| PROTAGONIST THERAPEUTICS INC | 1.11% | |
| INSMED INC | 1.06% | |
| NATERA INC | 1.06% | |
| SUMMIT THERAPEUTICS INC | 1.04% | |
| TENET HEALTHCARE CORP | 1.03% | |
| BRIGHTSPRING HEALTH SERVICES INC | 0.99% | |
| AMGEN INC | 0.99% | |
| BOSTON SCIENTIFIC CORP | 0.93% | |
| HCA HEALTHCARE INC | 0.92% | |
| GUARDANT HEALTH INC | 0.91% | |
| CVS HEALTH CORP | 0.86% | |
| KYMERA THERAPEUTICS INC | 0.77% | |
| THE CIGNA GROUP | 0.75% | |
| CG ONCOLOGY INC | 0.71% | |
| CARDINAL HEALTH INC | 0.69% | |
| ELEVANCE HEALTH INC | 0.67% | |
| KRYSTAL BIOTECH INC | 0.66% | |
| IONIS PHARMACEUTICALS INC | 0.63% | |
| SCHOLAR ROCK HOLDING CORP | 0.62% | |
| BRIDGEBIO PHARMA INC | 0.60% | |
| CHUGAI PHARMA CO | 0.58% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.56% | |
| PRAXIS PRECISION MEDICINES INC | 0.56% | |
| CELCUITY INC | 0.56% | |
| ROYALTY PHARMA PLC | 0.56% | |
| CENCORA INC | 0.53% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.50% | |
| VERA THERAPEUTICS INC | 0.47% | |
| NUVALENT INC-A | 0.45% | |
| T Rowe Price Government Reserve Investment Fund | 0.44% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.